Search

Some of the first clinical trials testing immunotherapy for the treatment of sarcoma are now under way at MSK. Here’s a snapshot of where the research stands.

… Monday, January 22, 2018 Summary Soft tissue sarcoma , a diverse group of cancers that arise in the body’s connective tissue, is difficult to treat after it has spread. MSK clinicians are investigating the use of immunotherapy to treat this disease. The main approaches involve checkpoint inhibitors and

The U.S. Food and Drug Administration (FDA) qualified MSK’s WOUND-Q™ questionnaire as a Medical Device Development Tool (MDDT) in November 2024.

… Thursday, January 23, 2025 The U.S. Food and Drug Administration (FDA) qualified MSK’s WOUND-Q™ questionnaire as a Medical Device Development Tool (MDDT) in November 2024. WOUND-Q is the latest of only 18 MDDTs that have earned the qualification since the MDDT program began in 2017. WOUND-Q contains

This story answers common questions about how your gut microbiota impacts your health, how to protect it, and the impact it has on diseases like cancer.

… Thursday, June 8, 2023 You may have heard the terms “gut microbiota” and “microbiome” and wondered what they mean and why they matter. Many researchers at Memorial Sloan Kettering Cancer Center (MSK) are studying how they influence the health of people with cancer and the general population, too. Here

Proton therapy offers a way to treat pediatric cancers more safely.

… Tuesday, June 18, 2019 Summary Children are especially sensitive to the side effects of conventional radiation therapy. For some pediatric cancers, proton therapy can be used to destroy tumors while minimizing risks. Radiation therapy is quite effective at shrinking or eliminating tumors. But doctors

Learn how MSK helped a man with stage 4 stomach (gastric) cancer using checkpoint inhibitors, a type of immunotherapy that also treats many other cancers.

… Thursday, July 3, 2025 Antonio Lekhrajmal knew his diagnosis of advanced  stomach cancer — also called gastric cancer — was extremely serious. He credits his doctor, Memorial Sloan Kettering Cancer Center (MSK) gastrointestinal oncologist Yelena Janjigian, MD , with being upfront with him, and treating

Physicians and scientists from MSK presented advances in transplantation and cellular therapies at the Tandem Meetings, a joint event hosted by the American Society for Transplantation and Cellular Therapy and the Center for International Blood and Marrow Transplant Research.

… Tuesday, February 25, 2025 Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) presented advances in transplantation and cellular therapies at the Tandem Meetings, a joint event hosted by the American Society for Transplantation and Cellular Therapy and the Center for International

Chris Lee’s story begins in the 1940s, when his maternal grandfather boarded a ship in China headed to America.

… Friday, May 27, 2022 Chris Lee’s story begins in the 1940s, when his maternal grandfather boarded a ship in China headed to America. Like tens of millions of immigrants, Mr. Wong entered the U.S. via Ellis Island Immigration Station, with the “hopes of making a better life for his family and their future

A new study led by researchers at Memorial Sloan Kettering Cancer Center (MSKCC) reports on a novel mechanism that can enhance the function of a protein that is frequently impaired in patients with acute forms of leukemia.

… Friday, February 29, 2008 A new study led by researchers at Memorial Sloan Kettering Cancer Center (MSKCC) reports on a novel mechanism that can enhance the function of a protein that is frequently impaired in patients with acute forms of leukemia. The protein, called AML1, plays a critical role in the

In a late-stage clinical trial, Hodgkin lymphoma patients who received brentuximab vedotin post-transplant lived longer without disease progression than patients who received only supportive care.

… Saturday, December 6, 2014 In a late-stage clinical trial, Hodgkin lymphoma (HL) patients who received brentuximab vedotin (BV) post-transplant lived longer without disease progression than patients who received only supportive care. This is the first time a study has demonstrated that adding a maintenance

Learn what detection of the polio virus in New York State means for you.

… Monday, September 12, 2022 Polio has been in the news after the poliovirus was detected in wastewater samples of several New York counties — including New York City — and a person was identified as having the disease by New York health officials in July. On September 9, Gov. Kathy Hochul declared a state